학술논문
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
Document Type
Article
Author
Gelderblom, Hans; Jones, Robin L.; Blay, Jean-Yves; George, Suzanne; von Mehren, Margaret; Zalcberg, John R.; Kang, Yoon-Koo; Razak, Albiruni Abdul; Trent, Jonathan; Attia, Steven; Le Cesne, Axel; Siontis, Brittany L.; Goldstein, David; Boye, Kjetil; Sanchez, Cesar; Steeghs, Neeltje; Rutkowski, Piotr; Druta, Mihaela; Serrano, César; Somaiah, Neeta; Chi, Ping; Harrow, Brooke; Becker, Claus; Reichmann, William; Sherman, Matthew L.; Ruiz-Soto, Rodrigo; Heinrich, Michael C.; Bauer, Sebastian
Source
In European Journal of Cancer October 2023 192
Subject
Language
ISSN
0959-8049